Technical Analysis for VCYT - Veracyte, Inc.
|Grade||Last Price||% Change||Price Change|
VCYT closed up 1.53 percent on Wednesday, January 16, 2019, on 1.64 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical VCYT trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 16||Pocket Pivot||Bullish Swing Setup||0.00%|
|Jan 16||Wide Bands||Range Expansion||0.00%|
|Jan 16||Overbought Stochastic||Strength||0.00%|
|Jan 15||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||1.53%|
|Jan 15||NR7||Range Contraction||1.53%|
|Jan 15||Wide Bands||Range Expansion||1.53%|
|Jan 15||Overbought Stochastic||Strength||1.53%|
|Jan 14||New Uptrend||Bullish||0.70%|
|Jan 14||Upper Bollinger Band Walk||Strength||0.70%|
|Jan 14||Wide Bands||Range Expansion||0.70%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more VCYT news...
|52 Week High||16.62|
|52 Week Low||5.23|
|200-Day Moving Average||10.2378|
|50-Day Moving Average||13.2085|
|20-Day Moving Average||13.435|
|10-Day Moving Average||15.095|
|Average True Range||0.9006|
|Chandelier Exit (Long, 3 ATRs )||13.9182|
|Chandelier Exit (Short, 3 ATRs )||13.4268|
|Upper Bollinger Band||17.0601|
|Lower Bollinger Band||9.8099|
|Percent B (%b)||0.84|
|MACD Signal Line||0.6605|
|Market Cap||539.92 Million|
|Num Shares||33.9 Million|
|Price-to-Earnings (P/E) Ratio||-19.91|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||17.49|
|Resistance 3 (R3)||17.53||17.06||17.23|
|Resistance 2 (R2)||17.06||16.66||17.04||17.14|
|Resistance 1 (R1)||16.49||16.41||16.78||16.45||17.06|
|Support 1 (S1)||15.45||15.62||15.74||15.41||14.80|
|Support 2 (S2)||14.98||15.37||14.96||14.72|
|Support 3 (S3)||14.41||14.98||14.63|
|Support 4 (S4)||14.37|